Cargando…
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
Food-grade Lactic Acid Bacteria (LAB) have been safely consumed for centuries by humans in fermented foods. Thus, they are good candidates to develop novel oral vectors, constituting attractive alternatives to attenuated pathogens, for mucosal delivery strategies. Herein, this review summarizes our...
Autores principales: | Bermúdez-Humarán, Luis G, Kharrat, Pascale, Chatel, Jean-Marc, Langella, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231930/ https://www.ncbi.nlm.nih.gov/pubmed/21995317 http://dx.doi.org/10.1186/1475-2859-10-S1-S4 |
Ejemplares similares
-
A new plasmid vector for DNA delivery using lactococci
por: Guimarães, Valeria, et al.
Publicado: (2009) -
Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci
por: Bermúdez-Humarán, Luis G, et al.
Publicado: (2015) -
Development of Mucosal Vaccines Based on Lactic Acid Bacteria
por: Bermúdez-Humarán, Luis G., et al.
Publicado: (2009) -
Heterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacterium
por: Cortes-Perez, Naima G, et al.
Publicado: (2009) -
Immunomodulatory mechanisms of lactobacilli
por: Wells, Jerry M
Publicado: (2011)